Human embryo polarization requires PLC signaling to mediate trophectoderm specification
Abstract
Apico-basal polarization of cells within the embryo is critical for the segregation of distinct lineages during mammalian development. Polarized cells become the trophectoderm (TE), which forms the placenta, and apolar cells become the inner cell mass (ICM), the founding population of the fetus. The cellular and molecular mechanisms leading to polarization of the human embryo and its timing during embryogenesis have remained unknown. Here, we show that human embryo polarization occurs in two steps: it begins with the apical enrichment of F-actin and is followed by the apical accumulation of the PAR complex. This two-step polarization process leads to the formation of an apical domain at the 8-16 cell stage. Using RNA interference, we show that apical domain formation requires Phospholipase C (PLC) signaling, specifically the enzymes PLCB1 and PLCE1, from the 8-cell stage onwards. Finally, we show that although expression of the critical TE differentiation marker GATA3 can be initiated independently of embryo polarization, downregulation of PLCB1 and PLCE1 decreases GATA3 expression through a reduction in the number of polarized cells. Therefore, apical domain formation reinforces a TE fate. The results we present here demonstrate how polarization is triggered to regulate the first lineage segregation in human embryos.
Data availability
Source data files used for generating each figure has been uploaded as supplementary material.
Article and author information
Author details
Funding
Wellcome Trust (207415/Z/17/Z)
- Magdalena Zernicka-Goetz
Open Philanthropy Project
- Magdalena Zernicka-Goetz
Curci and Weston Heavens Foundations
- Magdalena Zernicka-Goetz
Leverhulme Trust (RPG-2018-085)
- Meng Zhu
European molecular biology organisation
- Marta Shahbazi
Medical Research Council (MC_UP_1201/24)
- Marta Shahbazi
National Key Research and Development Program of China (2018YFC1004000)
- Zijiang Chen
Shandong Provincial Key Research and Development Program (2018YFJH0504)
- Zijiang Chen
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Joshua M Brickman, University of Copenhagen, Denmark
Ethics
Human subjects: Ethical approvalThis study was performed in five different avenues: Clinical Embryology Laboratory at IVIRMAValencia (Spain), University of Cambridge (United Kingdom), National Research Center forAssisted Reproductive Technology and Reproductive Genetics (China), California Institute ofTechnology (United States), and Foundation for Embryonic Competence New Jersey (UnitedStates). All the work complies with The International Society for Stem Cell Research (ISSCR)guidelines.Experiments performed in Spain: The work in the Clinical Embryology Laboratory at IVIRMAValencia was approved by the National Commission of Human Reproduction (CNRHA), theGeneral direction of research, innovation, technology and quality and the ethics committee ofClinical Research IVI Valencia, which complies with Spanish law on assisted reproductivetechnologies (14/2006). A total of 260 excess and cryopreserved donated day 3 humanembryos from 95 IVF patients were used. Embryos were not created for research. Couplesdonating their embryos were informed of the objectives of the project, the nature of theexperiments, and the conditions of the research. No financial inducements were offered fordonation. The average age of women was 28.12 {plus minus} 4. The fixed embryos were analysed at theUniversity of Cambridge. This work was evaluated by the Human Biology Research EthicsCommittee of the University of Cambridge (reference HBREC.2017.27).Experiments performed in the United Kingdom: The work performed at the University ofCambridge was in accordance with the Human Fertility and Embryology Authority (HFEA)regulations (license reference R0193). Ethical approval was obtained from the "HumanBiology Research Ethics Committee" of the University of Cambridge (referenceHBREC.2017.21). Informed consent was obtained from all patients from CARE Fertility Groupand Herts & Essex fertility clinics, who donated excess and cryopreserved embryos used inthis study after completing their IVF treatment. Embryos were not created for research. Priorto giving consent, patients were informed about the specific objectives of the project, and theconditions that apply within the license, offered counselling and did not receive any financialinducements. In this study, we used 15 donated embryos at the 2 pronuclei stage (day 1 d.p.f.),which were warmed and cultured in the Cambridge Laboratory according to the aboveregulations.Experiments performed in China: The work performed in the National Research Center forAssisted Reproductive Technology and Reproductive Genetics was conducted under theregulations of the Human Biomedical Research Ethics Guidelines (regulated by NationalHealth Commission of the People's Republic of China on 1 December 2016) and the HumanEmbryonic Stem Cell Research Ethics Guidelines (regulated by China National Center forBiotechnology Development on 24 December 2003). These regulations and guidelines allowexcess 3PN human gametes, and/or human embryos created or genetically manipulated invitro and those cultured for no more than 14 days, to be used for scientific researches. Theaim and protocols involved in this study were reviewed and approved by the InstitutionalReview Board (IRB) of Reproductive Medicine, Shandong University. The protocols includethe use of 3PN embryos and the siRNA injections. All embryos were donated after informedconsent was obtained. The embryos were excess and fresh 3PN zygotes generated from invitro fertilisation, with the donor females age ranging from 22 to 40 years old. These embryoswere used for microinjection experiments. Embryos were not created for research. Patientswere informed about the objectives, experimental approach and potential outcomes of theresearch prior to the donation. They were offered counselling to aid them in their decision.Experiments performed in California (United States): The work at California Institute ofTechnology was approved by the California Institute of Technology Committee for theProtection of Human Subjects (IRB number 19-0948). Human embryos at the zygote stagewere obtained from the University of Southern California (USC) through the pre-existing USCIRB-approved Biospecimen Repository for Reproductive Research (HS-15-00859) afterappropriate approval was obtained unanimously from the Biorepository Ethics Committee. AtUSC Fertility, excess cryopreserved embryos were donated after completion of IVF; embryoswere not created for research purposes. Patients were informed of the general conditions ofthe donation, objectives, and methodology of human embryo research. They were offeredcounselling and alternatives, including discarding embryos and continued cryopreservation.Patients were informed that they would not benefit directly from donation of embryos toresearch. A total of 41 donated human embryos at the zygote 2 pronuclei stage (day 1 postfertilisation.) from 4 IVF patients were used. The average age of women was 44. The embryoswere warmed at USC Fertility per usual IVF procedure and then transferred to the CaliforniaInstitute of Technology for the remainder of the protocol.Experiments performed in New Jersey (United States): the research was approved by theWestern IRB (Clinical IRB 20031397). Embryos used in this study were excess fresh embryosto the IVF treatment of IVI-RMA patients. Informed consent was obtained from all the couplesthat donated their embryos. They were informed of the general objective, methodology andpotential outcomes of the research. Patients did not receive any financial compensation forthe donation. Embryos were not created for research.
Version history
- Received: November 20, 2020
- Accepted: September 25, 2021
- Accepted Manuscript published: September 27, 2021 (version 1)
- Version of Record published: October 13, 2021 (version 2)
- Version of Record updated: October 19, 2021 (version 3)
Copyright
© 2021, Zhu et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,150
- views
-
- 611
- downloads
-
- 21
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Cell Biology
Mediator of ERBB2-driven Cell Motility 1 (MEMO1) is an evolutionary conserved protein implicated in many biological processes; however, its primary molecular function remains unknown. Importantly, MEMO1 is overexpressed in many types of cancer and was shown to modulate breast cancer metastasis through altered cell motility. To better understand the function of MEMO1 in cancer cells, we analyzed genetic interactions of MEMO1 using gene essentiality data from 1028 cancer cell lines and found multiple iron-related genes exhibiting genetic relationships with MEMO1. We experimentally confirmed several interactions between MEMO1 and iron-related proteins in living cells, most notably, transferrin receptor 2 (TFR2), mitoferrin-2 (SLC25A28), and the global iron response regulator IRP1 (ACO1). These interactions indicate that cells with high MEMO1 expression levels are hypersensitive to the disruptions in iron distribution. Our data also indicate that MEMO1 is involved in ferroptosis and is linked to iron supply to mitochondria. We have found that purified MEMO1 binds iron with high affinity under redox conditions mimicking intracellular environment and solved MEMO1 structures in complex with iron and copper. Our work reveals that the iron coordination mode in MEMO1 is very similar to that of iron-containing extradiol dioxygenases, which also display a similar structural fold. We conclude that MEMO1 is an iron-binding protein that modulates iron homeostasis in cancer cells.
-
- Cell Biology
- Chromosomes and Gene Expression
Heat stress is a major threat to global crop production, and understanding its impact on plant fertility is crucial for developing climate-resilient crops. Despite the known negative effects of heat stress on plant reproduction, the underlying molecular mechanisms remain poorly understood. Here, we investigated the impact of elevated temperature on centromere structure and chromosome segregation during meiosis in Arabidopsis thaliana. Consistent with previous studies, heat stress leads to a decline in fertility and micronuclei formation in pollen mother cells. Our results reveal that elevated temperature causes a decrease in the amount of centromeric histone and the kinetochore protein BMF1 at meiotic centromeres with increasing temperature. Furthermore, we show that heat stress increases the duration of meiotic divisions and prolongs the activity of the spindle assembly checkpoint during meiosis I, indicating an impaired efficiency of the kinetochore attachments to spindle microtubules. Our analysis of mutants with reduced levels of centromeric histone suggests that weakened centromeres sensitize plants to elevated temperature, resulting in meiotic defects and reduced fertility even at moderate temperatures. These results indicate that the structure and functionality of meiotic centromeres in Arabidopsis are highly sensitive to heat stress, and suggest that centromeres and kinetochores may represent a critical bottleneck in plant adaptation to increasing temperatures.